Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, Bertrand D, Bamoulid J, Louis M, Sberro Soussan R, Navarro D, Westeel PF, Frimat L, Colosio C, Thierry A, Rivalan J, Albano L, Arzouk N, Cornec-Le Gall E, Claisse G, Elias M, El Karoui K, Chauvet S, Coindre JP, Rerolle JP, Tricot L, Sayegh J, Garrouste C, Charasse C, Delmas Y, Massy Z, Hourmant M, Servais A, Loirat C, Fakhouri F, Pouteil-Noble C, Peraldi MN, Legendre C, Rondeau E, Le Quintrec M, Frémeaux-Bacchi V.

J Am Soc Nephrol. 2019 Oct 1. pii: ASN.2019040331. doi: 10.1681/ASN.2019040331. [Epub ahead of print]

PMID:
31575699
2.

Prognostic and Long-term Survival of Immune Thrombotic Thrombocytopenic Purpura in older patients.

Prevel R, Roubaud-Roubaud C, Gourlain S, Jamme M, Peres K, Benhamou Y, Galicier L, Azoulay E, Poullin P, Provôt F, Maury E, Presne C, Hamidou M, Saheb S, Wynckel A, Servais A, Girault S, Delmas Y, Chatelet V, Augusto JF Sr, Mousson C, Perez P, Halimi JM, Kanouni T, Lautrette A, Charvet Rumpler A, Deligny C, Chauveau D, Veyradier A Pr, Coppo P.

Blood. 2019 Sep 17. pii: blood.2019000748. doi: 10.1182/blood.2019000748. [Epub ahead of print]

PMID:
31530564
3.

Social deprivation is associated with poor kidney transplantation outcome in children.

Driollet B, Bayer F, Chatelet V, Macher MA, Salomon R, Ranchin B, Roussey G, Lahoche A, Garaix F, Decramer S, Mérieau E, Fila M, Zaloszyc A, Deschênes G, Valeri L, Launay L, Couchoud C, Leffondré K, Harambat J.

Kidney Int. 2019 Sep;96(3):769-776. doi: 10.1016/j.kint.2019.05.011. Epub 2019 May 28.

PMID:
31375259
4.

Transplant center characteristics associated with living-donor kidney transplantation: a cohort study with a hierarchical modeling approach.

Châtelet V, Gatault P, Hazzan M, Anglicheau D, Launoy G, Lobbedez T, Moulin B.

Transpl Int. 2019 Aug;32(8):865-875. doi: 10.1111/tri.13429. Epub 2019 Apr 2.

PMID:
30903630
5.

Cobalamin C Deficiency Induces a Typical Histopathological Pattern of Renal Arteriolar and Glomerular Thrombotic Microangiopathy.

Lemoine M, François A, Grangé S, Rabant M, Châtelet V, Cassiman D, Cornec-Le Gall E, Ambrosetti D, Deschênes G, Benoist JF, Guerrot D.

Kidney Int Rep. 2018 Jun 8;3(5):1153-1162. doi: 10.1016/j.ekir.2018.05.015. eCollection 2018 Sep.

6.

Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results.

Dantal J, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, Del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra A, Hofbauer GFL, Kamar N, Pouteil-Noble C, Kanitakis J, Roux A, Decullier E, Euvrard S; TUMORAPA Study Group.

J Clin Oncol. 2018 Sep 1;36(25):2612-2620. doi: 10.1200/JCO.2017.76.6691. Epub 2018 Jul 17.

PMID:
30016177
7.

Renal transplantation outcome and social deprivation in the French healthcare system: a cohort study using the European Deprivation Index.

Châtelet V, Bayat-Makoei S, Vigneau C, Launoy G, Lobbedez T.

Transpl Int. 2018 Oct;31(10):1089-1098. doi: 10.1111/tri.13161. Epub 2018 Apr 16.

8.

Eculizumab reversed severe distal ischemic syndrome and glomerulonephritis with isolated C3 deposits associated with anti-factor H autoantibodies: a case report.

Deshayes S, Martin Silva N, Chatelet V, Chantepie S, Le Quintrec M, Comoz F, Bridoux F, Dragon-Durey MA, Aouba A.

Clin Rheumatol. 2018 Apr;37(4):1119-1122. doi: 10.1007/s10067-018-4058-6. Epub 2018 Mar 7. Review.

PMID:
29516279
9.

[Socioeconomic inequalities and kidney transplantation].

Châtelet V, Lobbedez T, Harambat J, Bayat-Makoei S, Glowacki F, Vigneau C.

Nephrol Ther. 2018 Apr;14(2):81-84. doi: 10.1016/j.nephro.2017.04.003. Epub 2017 Dec 1. Review. French.

PMID:
29198520
10.

Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.

Bailly E, Anglicheau D, Blancho G, Gatault P, Vuiblet V, Chatelet V, Morelon E, Malvezzi P, Parissiadis A, Tourret J, Guidicelli G, Sayegh J, Mousson C, Grimbert P, Top I, Le Quintrec M, Purgus R, Westeel PF, Proust B, Chabot V, Lebranchu Y, Dehaut F, Büchler M.

Transplantation. 2018 Apr;102(4):688-698. doi: 10.1097/TP.0000000000002002.

PMID:
29135832
11.

[Outcome of living kidney donors for transplantation].

Lanot A, Bouvier N, Chatelet V, Lecouf A, Tillou X, Hurault de Ligny B.

Nephrol Ther. 2017 Nov;13(6):448-459. doi: 10.1016/j.nephro.2017.02.011. Epub 2017 Oct 12. Review. French.

PMID:
29031488
12.

Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study.

Bertrand D, Dehay J, Ott J, Sberro R, Brunelle C, Kamar N, Colosio C, Chatelet V, Albano L, Girerd S, Audard V, Barbet C, Dantal J, Ducloux D, Durrbach A, Garrigue V, Hazzan M, Heng AE, Mariat C, Merville P, Rerolle JP, Moulin B, Guerrot D.

Transpl Int. 2017 Mar;30(3):256-265. doi: 10.1111/tri.12923.

13.

Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.

Fakhouri F, Fila M, Provôt F, Delmas Y, Barbet C, Châtelet V, Rafat C, Cailliez M, Hogan J, Servais A, Karras A, Makdassi R, Louillet F, Coindre JP, Rondeau E, Loirat C, Frémeaux-Bacchi V.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):50-59. doi: 10.2215/CJN.06440616. Epub 2016 Oct 31.

14.

Successful renal retransplantation after graft loss from BK polyomavirus infection in a human immunodeficiency virus-positive patient.

Barthélemy A, Bouvier N, Verdon R, Chatelet V, Hurault de Ligny B.

Transpl Infect Dis. 2016 Dec;18(6):946-949. doi: 10.1111/tid.12615. Epub 2016 Nov 10.

PMID:
27717279
15.

Severe cryptococcal-associated neurological immune reconstitution inflammatory syndrome in a renal transplant recipient treated with adalimumab.

Deshayes S, Bouvier N, Chatelet V, Hurault de Ligny B, Dargère S, Bonhomme J, Béchade C.

Transpl Infect Dis. 2016 Jun;18(3):461-465. doi: 10.1111/tid.12522. Epub 2016 Apr 7.

PMID:
26929435
16.

[BK virus infections in kidney transplantation].

Lanot A, Bouvier N, Chatelet V, Dina J, Béchade C, Ficheux M, Henri P, Lobbedez T, Hurault de Ligny B.

Nephrol Ther. 2016 Apr;12(2):76-85. doi: 10.1016/j.nephro.2015.11.003. Epub 2016 Jan 28. French.

PMID:
26827190
17.

[PRETAGREF study: Prevalence of tobacco use and factors associated with smoking cessation in kidney transplant recipients].

Béchade C, Le Maître B, Lobbedez T, Bouvier N, Hurault de Ligny B, Châtelet V.

Nephrol Ther. 2016 Feb;12(1):48-55. doi: 10.1016/j.nephro.2015.08.001. Epub 2015 Nov 23. French.

PMID:
26616097
18.

One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial.

Sautenet B, Blancho G, Büchler M, Morelon E, Toupance O, Barrou B, Ducloux D, Chatelet V, Moulin B, Freguin C, Hazzan M, Lang P, Legendre C, Merville P, Mourad G, Mousson C, Pouteil-Noble C, Purgus R, Rerolle JP, Sayegh J, Westeel PF, Zaoui P, Boivin H, Le Gouge A, Lebranchu Y.

Transplantation. 2016 Feb;100(2):391-9. doi: 10.1097/TP.0000000000000958.

PMID:
26555944
19.

Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency.

Grangé S, Bekri S, Artaud-Macari E, Francois A, Girault C, Poitou AL, Benhamou Y, Vianey-Saban C, Benoist JF, Châtelet V, Tamion F, Guerrot D.

Lancet. 2015 Sep 5;386(9997):1011-2. doi: 10.1016/S0140-6736(15)00076-8. No abstract available.

PMID:
26369474
20.

Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.

Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Châtelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Frémeaux-Bacchi V.

Am J Kidney Dis. 2014 Jan;63(1):40-8. doi: 10.1053/j.ajkd.2013.07.011. Epub 2013 Sep 8.

PMID:
24021908
21.

Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.

Le Quintrec M, Zuber J, Moulin B, Kamar N, Jablonski M, Lionet A, Chatelet V, Mousson C, Mourad G, Bridoux F, Cassuto E, Loirat C, Rondeau E, Delahousse M, Frémeaux-Bacchi V.

Am J Transplant. 2013 Mar;13(3):663-75. doi: 10.1111/ajt.12077. Epub 2013 Jan 28.

22.

Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.

Zuber J, Le Quintrec M, Krid S, Bertoye C, Gueutin V, Lahoche A, Heyne N, Ardissino G, Chatelet V, Noël LH, Hourmant M, Niaudet P, Frémeaux-Bacchi V, Rondeau E, Legendre C, Loirat C; French Study Group for Atypical HUS.

Am J Transplant. 2012 Dec;12(12):3337-54. doi: 10.1111/j.1600-6143.2012.04252.x. Epub 2012 Sep 7.

23.

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

Euvrard S, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra AL, Hofbauer GF, Pouteil-Noble C, Campistol JM, Kanitakis J, Roux AS, Decullier E, Dantal J; TUMORAPA Study Group.

N Engl J Med. 2012 Jul 26;367(4):329-39. doi: 10.1056/NEJMoa1204166.

24.

Renal resistive index as a new independent risk factor for new-onset diabetes mellitus after kidney transplantation.

Mutinelli-Szymanski P, Caille A, Tranquart F, Al-Najjar A, Büchler M, Barbet C, Marlière JF, Gatault P, Réault J, Boin C, Chatelet V, Laouad I, Nivet H, Lebranchu Y, Halimi JM.

Transpl Int. 2012 Apr;25(4):464-70. doi: 10.1111/j.1432-2277.2012.01445.x. Epub 2012 Feb 24.

25.

Hydration status of patients with end-stage renal disease after kidney transplantation.

Gueutin V, Ficheux M, Châtelet V, Lecouf A, Henri P, Hurault de Ligny B, Ryckelynck JP, Lobbedez T.

Clin Transplant. 2011 Nov-Dec;25(6):E656-63. doi: 10.1111/j.1399-0012.2011.01496.x. Epub 2011 Aug 24.

PMID:
21883475
26.

Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report.

Châtelet V, Lobbedez T, Frémeaux-Bacchi V, Ficheux M, Ryckelynck JP, Hurault de Ligny B.

Transplant Proc. 2010 Dec;42(10):4353-5. doi: 10.1016/j.transproceed.2010.09.125.

PMID:
21168697
27.

Complicated lymphoceles after kidney transplantation.

Zagdoun E, Ficheux M, Lobbedez T, Chatelet V, Thuillier-Lecouf A, Bensadoun H, Ryckelynck JP, Hurault de Ligny B.

Transplant Proc. 2010 Dec;42(10):4322-5. doi: 10.1016/j.transproceed.2010.09.127.

PMID:
21168691
28.

Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome.

Chatelet V, Frémeaux-Bacchi V, Lobbedez T, Ficheux M, Hurault de Ligny B.

Am J Transplant. 2009 Nov;9(11):2644-5. doi: 10.1111/j.1600-6143.2009.02817.x. Epub 2009 Sep 22. No abstract available.

29.

Pulmonary zygomycosis in solid organ transplant recipients in the current era.

Sun HY, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, John GT, Pursell KJ, Muñoz P, Patel R, Fortun J, Martin-Davila P, Philippe B, Philit F, Tabah A, Terzi N, Chatelet V, Kusne S, Clark N, Blumberg E, Julia MB, Humar A, Houston S, Lass-Florl C, Johnson L, Dubberke ER, Barron MA, Lortholary O, Singh N; Zygomycosis Transplant Study Group.

Am J Transplant. 2009 Sep;9(9):2166-71. doi: 10.1111/j.1600-6143.2009.02754.x. Epub 2009 Jul 22.

30.

Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome.

Singh N, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, John GT, Pursell KJ, Muñoz P, Patel R, Fortun J, Martin-Davila P, Philippe B, Philit F, Tabah A, Terzi N, Chatelet V, Kusne S, Clark N, Blumberg E, Julia MB, Humar A, Houston S, Lass-Flörl C, Johnson L, Dubberke ER, Barron MA, Lortholary O.

J Infect Dis. 2009 Sep 15;200(6):1002-11. doi: 10.1086/605445.

PMID:
19659439
31.

[Medical and economic evaluation of new peritoneal dialysis solutions].

Ryckelynck JP, Lobbedez T, Ficheux M, Chatelet V, Thuillier-Lecouf A, Henri P, Hurault de Ligny B.

Nephrol Ther. 2009 Jun;5 Suppl 4:S286-9. doi: 10.1016/S1769-7255(09)74560-2. French.

PMID:
19596350
32.

[Is clinical judgment a suitable method to select marginal allograft for transplantation? A single centre experience].

Abbadie O, Lobbedez T, Ficheux M, El Haggan W, Chatelet V, Levaltier B, Henri P, Ryckelynck JP, Hurault de Ligny B.

Nephrol Ther. 2009 Nov;5(6):559-67. doi: 10.1016/j.nephro.2009.05.004. Epub 2009 Jul 8. French.

PMID:
19589742
33.

Early pulse pressure and low-grade proteinuria as independent long-term risk factors for new-onset diabetes mellitus after kidney transplantation.

Roland M, Gatault P, Al-Najjar A, Doute C, Barbet C, Chatelet V, Laouad I, Marlière JF, Nivet H, Büchler M, Lebranchu Y, Halimi JM.

Am J Transplant. 2008 Aug;8(8):1719-28. doi: 10.1111/j.1600-6143.2008.02308.x.

34.

Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.

Roland M, Gatault P, Doute C, Büchler M, Al-Najjar A, Barbet C, Chatelet V, Marlière JF, Nivet H, Lebranchu Y, Halimi JM.

Transpl Int. 2008 Jun;21(6):523-30. doi: 10.1111/j.1432-2277.2008.00640.x. Epub 2008 Feb 4.

35.

Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients.

Halimi JM, Matthias B, Al-Najjar A, Laouad I, Chatelet V, Marlière JF, Nivet H, Lebranchu Y.

Am J Transplant. 2007 Dec;7(12):2775-81. Epub 2007 Oct 19.

36.

[News in peritoneal dialysis].

Ryckelynck JP, Lobbedez T, Ficheux M, Bonnamy C, El Haggan W, Henri P, Chatelet V, Levaltier B, Hurault de Ligny B.

Presse Med. 2007 Dec;36(12 Pt 2):1823-8. Epub 2007 Jul 25. Review. French.

PMID:
17656064
37.

Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients.

Halimi JM, Buchler M, Al-Najjar A, Laouad I, Chatelet V, Marlière JF, Nivet H, Lebranchu Y.

Am J Transplant. 2007 Mar;7(3):618-25. Epub 2007 Jan 11.

38.

Early proteinuria is a strong indicator of donor renal lesions, ischemia-reperfusion injury and immunological aggression.

Halimi J, Laouad I, Buchler M, Al-Najjar A, Chatelet V, Houssaini TS, Nivet H, Lebranchu Y.

Transplant Proc. 2006 Sep;38(7):2319-20.

PMID:
16980078
39.

Recipient age and mycophenolate mofetil as the main determinants of outcome after steroid withdrawal: analysis of long-term follow-up in renal transplantation.

Laouad I, Halimi JM, Büchler M, Al-Najjar A, Chatelet V, Nivet H, Lebranchu Y.

Transplantation. 2005 Sep 27;80(6):872-4.

PMID:
16210979
40.

Early low-grade proteinuria: causes, short-term evolution and long-term consequences in renal transplantation.

Halimi JM, Laouad I, Buchler M, Al-Najjar A, Chatelet V, Houssaini TS, Nivet H, Lebranchu Y.

Am J Transplant. 2005 Sep;5(9):2281-8.

Supplemental Content

Loading ...
Support Center